Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP644266.RAKSggo1dQmt4VCRUYKWDMrDVuHzLOniKUQnmMq3f-OvU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP644266.RAKSggo1dQmt4VCRUYKWDMrDVuHzLOniKUQnmMq3f-OvU130_assertion type Assertion NP644266.RAKSggo1dQmt4VCRUYKWDMrDVuHzLOniKUQnmMq3f-OvU130_head.
- NP644266.RAKSggo1dQmt4VCRUYKWDMrDVuHzLOniKUQnmMq3f-OvU130_assertion description "[Western blot and immunohistochemical analyses have also shown a progressive loss of p75(NTR) expression in prostate epithelial cells during the malignant progression of organ-confined adenocarcinomas, with complete loss of expression in the naturally occurring prostate tumor cell lines DU-145, PC-3, LNCaP, and TSU-pr1, which were derived from metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644266.RAKSggo1dQmt4VCRUYKWDMrDVuHzLOniKUQnmMq3f-OvU130_provenance.
- NP644266.RAKSggo1dQmt4VCRUYKWDMrDVuHzLOniKUQnmMq3f-OvU130_assertion evidence source_evidence_literature NP644266.RAKSggo1dQmt4VCRUYKWDMrDVuHzLOniKUQnmMq3f-OvU130_provenance.
- NP644266.RAKSggo1dQmt4VCRUYKWDMrDVuHzLOniKUQnmMq3f-OvU130_assertion SIO_000772 11398197 NP644266.RAKSggo1dQmt4VCRUYKWDMrDVuHzLOniKUQnmMq3f-OvU130_provenance.
- NP644266.RAKSggo1dQmt4VCRUYKWDMrDVuHzLOniKUQnmMq3f-OvU130_assertion wasDerivedFrom befree-20140225 NP644266.RAKSggo1dQmt4VCRUYKWDMrDVuHzLOniKUQnmMq3f-OvU130_provenance.
- NP644266.RAKSggo1dQmt4VCRUYKWDMrDVuHzLOniKUQnmMq3f-OvU130_assertion wasGeneratedBy ECO_0000203 NP644266.RAKSggo1dQmt4VCRUYKWDMrDVuHzLOniKUQnmMq3f-OvU130_provenance.